Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on October 16th, 2017 by Betsy Davis in Pharma R&D
In Norway, a land that evokes images of rough-hewn Scandinavians, icy natural beauty and old wooden Viking ships, there is in fact a great deal of investment currently being put into not-so-rugged things like cutting-edge new labs and state-of-the-art scientific research.
Posted on October 11th, 2017 by Christy J. Wilson in Pharma R&D
Researchers are always looking for new ways to attack cancer, and the scientists at Boston-based biotech start-up Rubius Therapeutics have happened upon an unexpected ally: the red blood cell.
Posted on October 3rd, 2017 by Dr Andrew A. Parsons in Pharma R&D
It was not so long ago that there was a perception that the biopharma industry was consolidating and becoming leaner and more focused in its operations, moving to a regional hotspot model Continue reading “From mega-merger to big bang?” »
Posted on August 4th, 2017 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
Just last week, US FDA Commissioner Dr. Scott Gottlieb published a blog on the FDA web site that talks about new policies the FDA is going to be acting upon. These new policies are designed to empower the consumer to act on his own and allow ‘digital healthcare’ technologies to help promote better health. Continue reading “A New Innovative Approach: Application of Digital Healthcare” »